<?xml version="1.0"?>
<rss version="2.0">
 <channel>
  <title>StreetInsider.com News Articles</title>
  <link>http://www.streetinsider.com</link>
  <description>Latest StreetInsider.com News Articles</description>
  <language>en-us</language>
  <copyright>Copyright 2026, StreetInsider.com</copyright>
  <managingEditor>rss@streetinsider.com (SI RSS)</managingEditor>
  <webMaster>rss@streetinsider.com (SI RSS)</webMaster>
  <lastBuildDate>Mon, 22 Jun 2026 13:26:00 -0400</lastBuildDate>
  <docs>http://blogs.law.harvard.edu/tech/rss</docs>
  <image>
   <url>http://www.streetinsider.com/images/rss_logo.gif</url>
   <title>StreetInsider.com News Articles</title>
   <link>http://www.streetinsider.com</link>
   <width>143</width>
   <height>28</height>
  </image>
  <skipHours>
   <hour>0</hour>
   <hour>1</hour>
   <hour>2</hour>
   <hour>3</hour>
   <hour>21</hour>
   <hour>22</hour>
   <hour>23</hour>
  </skipHours>
  <skipDays>
   <day>Saturday</day>
   <day>Sunday</day>
  </skipDays>
  <item>
   <title>Form  4          Conexeu Sciences Inc.     For: Jun 18  Filed by: Wright Michael G.</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Conexeu+Sciences+Inc.+++++For%3A+Jun+18++Filed+by%3A+Wright+Michael+G./26672137.html</link>
   <description>si-local-file:///var/storage/secattach/20260622/26672137.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Conexeu+Sciences+Inc.+++++For%3A+Jun+18++Filed+by%3A+Wright+Michael+G./26672137.html</guid>
   <pubDate>Mon, 22 Jun 2026 13:26:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">CNXU</category>
   	  </item>
  <item>
   <title>H.C. Wainwright Starts Conexeu Sciences (CNXU) at Buy</title>
   <link>http://www.streetinsider.com/New+Coverage/H.C.+Wainwright+Starts+Conexeu+Sciences+%28CNXU%29+at+Buy/26669433.html</link>
   <description>(Updated - June 22, 2026 6:21 AM EDT)

&lt;p&gt;H.C. Wainwright analyst Swayampakula Ramakanth initiates coverage on Conexeu Sciences (NASDAQ: CNXU) with a Buy rating and a price target of $20.00.&lt;/p&gt;&lt;p&gt;The analyst commented: &quot;CXU is a differentiated tissue product with a cross-vertical opportunity of ~$20B. We are initiating coverage of Conexeu Sciences with a Buy rating and a 12-month price target of $20 per diluted share. Conexeu is a pre-commercial-stage regenerative medicine company, and its lead asset, CXU, is a differentiated, injectable collagen-based tissue-agnostic biomaterial with potential utility across a combined addressable market of $20B, which has strong IP protection to early</description>
   <guid isPermaLink="true">http://www.streetinsider.com/New+Coverage/H.C.+Wainwright+Starts+Conexeu+Sciences+%28CNXU%29+at+Buy/26669433.html</guid>
   <pubDate>Mon, 22 Jun 2026 06:21:29 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">CNXU</category>
   	  </item>
  <item>
   <title>H.C. Wainwright Starts Conexeu Sciences (CNXU) at Buy</title>
   <link>http://www.streetinsider.com/Analyst+Comments/H.C.+Wainwright+Starts+Conexeu+Sciences+%28CNXU%29+at+Buy/26669433.html</link>
   <description>(Updated - June 22, 2026 6:21 AM EDT)

&lt;p&gt;H.C. Wainwright analyst Swayampakula Ramakanth initiates coverage on Conexeu Sciences (NASDAQ: CNXU) with a Buy rating and a price target of $20.00.&lt;/p&gt;&lt;p&gt;The analyst commented: &quot;CXU is a differentiated tissue product with a cross-vertical opportunity of ~$20B. We are initiating coverage of Conexeu Sciences with a Buy rating and a 12-month price target of $20 per diluted share. Conexeu is a pre-commercial-stage regenerative medicine company, and its lead asset, CXU, is a differentiated, injectable collagen-based tissue-agnostic biomaterial with potential utility across a combined addressable market of $20B, which has strong IP protection to early</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Analyst+Comments/H.C.+Wainwright+Starts+Conexeu+Sciences+%28CNXU%29+at+Buy/26669433.html</guid>
   <pubDate>Mon, 22 Jun 2026 06:21:29 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">CNXU</category>
   	  </item>
  <item>
   <title>Regenerative Medicine’s Next Chapter: Inside the Race to Make the Body Rebuild Itself</title>
   <link>http://www.streetinsider.com/Press+Releases/Regenerative+Medicine%E2%80%99s+Next+Chapter%3A+Inside+the+Race+to+Make+the+Body+Rebuild+Itself/26664866.html</link>
   <description>&lt;p align=&quot;left&quot;&gt;&lt;em&gt;Issued on behalf of Conexeu Sciences Inc.&lt;/em&gt;&lt;/p&gt;  &lt;p align=&quot;left&quot;&gt;&lt;em&gt;A sector analysis of regenerative medicine — the science of restoring tissue rather than merely replacing it — and where a new generation of platform companies is trying to fit in.&lt;/em&gt;&lt;/p&gt;  &lt;p align=&quot;left&quot;&gt;NEW YORK, June  18, 2026  (GLOBE NEWSWIRE) -- &lt;a href=&quot;https://www.globenewswire.com/Tracker?data=DVJrA7TbaSHoWZvxL--foowzGT77LPmehJOoPML5DOle2A_51c37s7Kzcz-Az7mGx8adJ7a9Rw4eGl7kGwyE-VQJuYIGzG8LodVu_rogI6Q=&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;Biotech Insider&lt;/a&gt; News Commentary — For most of medical history, the human body’s inability to regrow lost tissue has been treated as a limitation to be managed rather than a problem to be solved. When skin, bone, or soft tissue is destroyed by injury,</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Regenerative+Medicine%E2%80%99s+Next+Chapter%3A+Inside+the+Race+to+Make+the+Body+Rebuild+Itself/26664866.html</guid>
   <pubDate>Thu, 18 Jun 2026 12:42:37 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">CNXU</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CNXU</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">IART</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">MDXG</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ORGO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">VCEL</category>
   	  </item>
  <item>
   <title>Regenerative Medicine’s Next Chapter: Inside the Race to Make the Body Rebuild Itself</title>
   <link>http://www.streetinsider.com/Press+Releases/Regenerative+Medicine%E2%80%99s+Next+Chapter%3A+Inside+the+Race+to+Make+the+Body+Rebuild+Itself/26664866.html</link>
   <description>&lt;p align=&quot;left&quot;&gt;&lt;em&gt;Issued on behalf of Conexeu Sciences Inc.&lt;/em&gt;&lt;/p&gt;  &lt;p align=&quot;left&quot;&gt;&lt;em&gt;A sector analysis of regenerative medicine — the science of restoring tissue rather than merely replacing it — and where a new generation of platform companies is trying to fit in.&lt;/em&gt;&lt;/p&gt;  &lt;p align=&quot;left&quot;&gt;NEW YORK, June  18, 2026  (GLOBE NEWSWIRE) -- &lt;a href=&quot;https://www.globenewswire.com/Tracker?data=DVJrA7TbaSHoWZvxL--foowzGT77LPmehJOoPML5DOle2A_51c37s7Kzcz-Az7mGx8adJ7a9Rw4eGl7kGwyE-VQJuYIGzG8LodVu_rogI6Q=&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;Biotech Insider&lt;/a&gt; News Commentary — For most of medical history, the human body’s inability to regrow lost tissue has been treated as a limitation to be managed rather than a problem to be solved. When skin, bone, or soft tissue is destroyed by injury,</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Regenerative+Medicine%E2%80%99s+Next+Chapter%3A+Inside+the+Race+to+Make+the+Body+Rebuild+Itself/26664866.html</guid>
   <pubDate>Thu, 18 Jun 2026 12:42:37 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">CNXU</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CNXU</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">IART</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">MDXG</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ORGO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">VCEL</category>
   	  </item>
  <item>
   <title>Regenerative Medicine’s Next Chapter: Inside the Race to Make the Body Rebuild Itself</title>
   <link>http://www.streetinsider.com/Press+Releases/Regenerative+Medicine%E2%80%99s+Next+Chapter%3A+Inside+the+Race+to+Make+the+Body+Rebuild+Itself/26664866.html</link>
   <description>&lt;p align=&quot;left&quot;&gt;&lt;em&gt;Issued on behalf of Conexeu Sciences Inc.&lt;/em&gt;&lt;/p&gt;  &lt;p align=&quot;left&quot;&gt;&lt;em&gt;A sector analysis of regenerative medicine — the science of restoring tissue rather than merely replacing it — and where a new generation of platform companies is trying to fit in.&lt;/em&gt;&lt;/p&gt;  &lt;p align=&quot;left&quot;&gt;NEW YORK, June  18, 2026  (GLOBE NEWSWIRE) -- &lt;a href=&quot;https://www.globenewswire.com/Tracker?data=DVJrA7TbaSHoWZvxL--foowzGT77LPmehJOoPML5DOle2A_51c37s7Kzcz-Az7mGx8adJ7a9Rw4eGl7kGwyE-VQJuYIGzG8LodVu_rogI6Q=&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;Biotech Insider&lt;/a&gt; News Commentary — For most of medical history, the human body’s inability to regrow lost tissue has been treated as a limitation to be managed rather than a problem to be solved. When skin, bone, or soft tissue is destroyed by injury,</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Regenerative+Medicine%E2%80%99s+Next+Chapter%3A+Inside+the+Race+to+Make+the+Body+Rebuild+Itself/26664866.html</guid>
   <pubDate>Thu, 18 Jun 2026 12:42:37 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">CNXU</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CNXU</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">IART</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">MDXG</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ORGO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">VCEL</category>
   	  </item>
  <item>
   <title>Regenerative Medicine’s Next Chapter: Inside the Race to Make the Body Rebuild Itself</title>
   <link>http://www.streetinsider.com/Press+Releases/Regenerative+Medicine%E2%80%99s+Next+Chapter%3A+Inside+the+Race+to+Make+the+Body+Rebuild+Itself/26664866.html</link>
   <description>&lt;p align=&quot;left&quot;&gt;&lt;em&gt;Issued on behalf of Conexeu Sciences Inc.&lt;/em&gt;&lt;/p&gt;  &lt;p align=&quot;left&quot;&gt;&lt;em&gt;A sector analysis of regenerative medicine — the science of restoring tissue rather than merely replacing it — and where a new generation of platform companies is trying to fit in.&lt;/em&gt;&lt;/p&gt;  &lt;p align=&quot;left&quot;&gt;NEW YORK, June  18, 2026  (GLOBE NEWSWIRE) -- &lt;a href=&quot;https://www.globenewswire.com/Tracker?data=DVJrA7TbaSHoWZvxL--foowzGT77LPmehJOoPML5DOle2A_51c37s7Kzcz-Az7mGx8adJ7a9Rw4eGl7kGwyE-VQJuYIGzG8LodVu_rogI6Q=&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;Biotech Insider&lt;/a&gt; News Commentary — For most of medical history, the human body’s inability to regrow lost tissue has been treated as a limitation to be managed rather than a problem to be solved. When skin, bone, or soft tissue is destroyed by injury,</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Regenerative+Medicine%E2%80%99s+Next+Chapter%3A+Inside+the+Race+to+Make+the+Body+Rebuild+Itself/26664866.html</guid>
   <pubDate>Thu, 18 Jun 2026 12:42:37 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">CNXU</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CNXU</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">IART</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">MDXG</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ORGO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">VCEL</category>
   	  </item>
  <item>
   <title>Regenerative Medicine’s Next Chapter: Inside the Race to Make the Body Rebuild Itself</title>
   <link>http://www.streetinsider.com/Press+Releases/Regenerative+Medicine%E2%80%99s+Next+Chapter%3A+Inside+the+Race+to+Make+the+Body+Rebuild+Itself/26664866.html</link>
   <description>&lt;p align=&quot;left&quot;&gt;&lt;em&gt;Issued on behalf of Conexeu Sciences Inc.&lt;/em&gt;&lt;/p&gt;  &lt;p align=&quot;left&quot;&gt;&lt;em&gt;A sector analysis of regenerative medicine — the science of restoring tissue rather than merely replacing it — and where a new generation of platform companies is trying to fit in.&lt;/em&gt;&lt;/p&gt;  &lt;p align=&quot;left&quot;&gt;NEW YORK, June  18, 2026  (GLOBE NEWSWIRE) -- &lt;a href=&quot;https://www.globenewswire.com/Tracker?data=DVJrA7TbaSHoWZvxL--foowzGT77LPmehJOoPML5DOle2A_51c37s7Kzcz-Az7mGx8adJ7a9Rw4eGl7kGwyE-VQJuYIGzG8LodVu_rogI6Q=&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;Biotech Insider&lt;/a&gt; News Commentary — For most of medical history, the human body’s inability to regrow lost tissue has been treated as a limitation to be managed rather than a problem to be solved. When skin, bone, or soft tissue is destroyed by injury,</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Regenerative+Medicine%E2%80%99s+Next+Chapter%3A+Inside+the+Race+to+Make+the+Body+Rebuild+Itself/26664866.html</guid>
   <pubDate>Thu, 18 Jun 2026 12:42:37 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">CNXU</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CNXU</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">IART</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">MDXG</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ORGO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">VCEL</category>
   	  </item>
  <item>
   <title>Regenerative Medicine’s Next Chapter: Inside the Race to Make the Body Rebuild Itself</title>
   <link>http://www.streetinsider.com/Press+Releases/Regenerative+Medicine%E2%80%99s+Next+Chapter%3A+Inside+the+Race+to+Make+the+Body+Rebuild+Itself/26664866.html</link>
   <description>&lt;p align=&quot;left&quot;&gt;&lt;em&gt;Issued on behalf of Conexeu Sciences Inc.&lt;/em&gt;&lt;/p&gt;  &lt;p align=&quot;left&quot;&gt;&lt;em&gt;A sector analysis of regenerative medicine — the science of restoring tissue rather than merely replacing it — and where a new generation of platform companies is trying to fit in.&lt;/em&gt;&lt;/p&gt;  &lt;p align=&quot;left&quot;&gt;NEW YORK, June  18, 2026  (GLOBE NEWSWIRE) -- &lt;a href=&quot;https://www.globenewswire.com/Tracker?data=DVJrA7TbaSHoWZvxL--foowzGT77LPmehJOoPML5DOle2A_51c37s7Kzcz-Az7mGx8adJ7a9Rw4eGl7kGwyE-VQJuYIGzG8LodVu_rogI6Q=&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;Biotech Insider&lt;/a&gt; News Commentary — For most of medical history, the human body’s inability to regrow lost tissue has been treated as a limitation to be managed rather than a problem to be solved. When skin, bone, or soft tissue is destroyed by injury,</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Regenerative+Medicine%E2%80%99s+Next+Chapter%3A+Inside+the+Race+to+Make+the+Body+Rebuild+Itself/26664866.html</guid>
   <pubDate>Thu, 18 Jun 2026 12:42:37 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">CNXU</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CNXU</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">IART</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">MDXG</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ORGO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">VCEL</category>
   	  </item>
  <item>
   <title>Regenerative Medicine’s Next Chapter: Inside the Race to Make the Body Rebuild Itself</title>
   <link>http://www.streetinsider.com/Globe+Newswire/Regenerative+Medicine%E2%80%99s+Next+Chapter%3A+Inside+the+Race+to+Make+the+Body+Rebuild+Itself/26664866.html</link>
   <description>&lt;p align=&quot;left&quot;&gt;&lt;em&gt;Issued on behalf of Conexeu Sciences Inc.&lt;/em&gt;&lt;/p&gt;  &lt;p align=&quot;left&quot;&gt;&lt;em&gt;A sector analysis of regenerative medicine — the science of restoring tissue rather than merely replacing it — and where a new generation of platform companies is trying to fit in.&lt;/em&gt;&lt;/p&gt;  &lt;p align=&quot;left&quot;&gt;NEW YORK, June  18, 2026  (GLOBE NEWSWIRE) -- &lt;a href=&quot;https://www.globenewswire.com/Tracker?data=DVJrA7TbaSHoWZvxL--foowzGT77LPmehJOoPML5DOle2A_51c37s7Kzcz-Az7mGx8adJ7a9Rw4eGl7kGwyE-VQJuYIGzG8LodVu_rogI6Q=&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;Biotech Insider&lt;/a&gt; News Commentary — For most of medical history, the human body’s inability to regrow lost tissue has been treated as a limitation to be managed rather than a problem to be solved. When skin, bone, or soft tissue is destroyed by injury,</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/Regenerative+Medicine%E2%80%99s+Next+Chapter%3A+Inside+the+Race+to+Make+the+Body+Rebuild+Itself/26664866.html</guid>
   <pubDate>Thu, 18 Jun 2026 12:42:37 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">CNXU</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CNXU</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">IART</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">MDXG</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ORGO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">VCEL</category>
   	  </item>
  <item>
   <title>Regenerative Medicine’s Next Chapter: Inside the Race to Make the Body Rebuild Itself</title>
   <link>http://www.streetinsider.com/Globe+Newswire/Regenerative+Medicine%E2%80%99s+Next+Chapter%3A+Inside+the+Race+to+Make+the+Body+Rebuild+Itself/26664866.html</link>
   <description>&lt;p align=&quot;left&quot;&gt;&lt;em&gt;Issued on behalf of Conexeu Sciences Inc.&lt;/em&gt;&lt;/p&gt;  &lt;p align=&quot;left&quot;&gt;&lt;em&gt;A sector analysis of regenerative medicine — the science of restoring tissue rather than merely replacing it — and where a new generation of platform companies is trying to fit in.&lt;/em&gt;&lt;/p&gt;  &lt;p align=&quot;left&quot;&gt;NEW YORK, June  18, 2026  (GLOBE NEWSWIRE) -- &lt;a href=&quot;https://www.globenewswire.com/Tracker?data=DVJrA7TbaSHoWZvxL--foowzGT77LPmehJOoPML5DOle2A_51c37s7Kzcz-Az7mGx8adJ7a9Rw4eGl7kGwyE-VQJuYIGzG8LodVu_rogI6Q=&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;Biotech Insider&lt;/a&gt; News Commentary — For most of medical history, the human body’s inability to regrow lost tissue has been treated as a limitation to be managed rather than a problem to be solved. When skin, bone, or soft tissue is destroyed by injury,</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/Regenerative+Medicine%E2%80%99s+Next+Chapter%3A+Inside+the+Race+to+Make+the+Body+Rebuild+Itself/26664866.html</guid>
   <pubDate>Thu, 18 Jun 2026 12:42:37 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">CNXU</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CNXU</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">IART</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">MDXG</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ORGO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">VCEL</category>
   	  </item>
  <item>
   <title>Regenerative Medicine’s Next Chapter: Inside the Race to Make the Body Rebuild Itself</title>
   <link>http://www.streetinsider.com/Globe+Newswire/Regenerative+Medicine%E2%80%99s+Next+Chapter%3A+Inside+the+Race+to+Make+the+Body+Rebuild+Itself/26664866.html</link>
   <description>&lt;p align=&quot;left&quot;&gt;&lt;em&gt;Issued on behalf of Conexeu Sciences Inc.&lt;/em&gt;&lt;/p&gt;  &lt;p align=&quot;left&quot;&gt;&lt;em&gt;A sector analysis of regenerative medicine — the science of restoring tissue rather than merely replacing it — and where a new generation of platform companies is trying to fit in.&lt;/em&gt;&lt;/p&gt;  &lt;p align=&quot;left&quot;&gt;NEW YORK, June  18, 2026  (GLOBE NEWSWIRE) -- &lt;a href=&quot;https://www.globenewswire.com/Tracker?data=DVJrA7TbaSHoWZvxL--foowzGT77LPmehJOoPML5DOle2A_51c37s7Kzcz-Az7mGx8adJ7a9Rw4eGl7kGwyE-VQJuYIGzG8LodVu_rogI6Q=&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;Biotech Insider&lt;/a&gt; News Commentary — For most of medical history, the human body’s inability to regrow lost tissue has been treated as a limitation to be managed rather than a problem to be solved. When skin, bone, or soft tissue is destroyed by injury,</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/Regenerative+Medicine%E2%80%99s+Next+Chapter%3A+Inside+the+Race+to+Make+the+Body+Rebuild+Itself/26664866.html</guid>
   <pubDate>Thu, 18 Jun 2026 12:42:37 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">CNXU</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CNXU</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">IART</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">MDXG</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ORGO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">VCEL</category>
   	  </item>
  <item>
   <title>Regenerative Medicine’s Next Chapter: Inside the Race to Make the Body Rebuild Itself</title>
   <link>http://www.streetinsider.com/Globe+Newswire/Regenerative+Medicine%E2%80%99s+Next+Chapter%3A+Inside+the+Race+to+Make+the+Body+Rebuild+Itself/26664866.html</link>
   <description>&lt;p align=&quot;left&quot;&gt;&lt;em&gt;Issued on behalf of Conexeu Sciences Inc.&lt;/em&gt;&lt;/p&gt;  &lt;p align=&quot;left&quot;&gt;&lt;em&gt;A sector analysis of regenerative medicine — the science of restoring tissue rather than merely replacing it — and where a new generation of platform companies is trying to fit in.&lt;/em&gt;&lt;/p&gt;  &lt;p align=&quot;left&quot;&gt;NEW YORK, June  18, 2026  (GLOBE NEWSWIRE) -- &lt;a href=&quot;https://www.globenewswire.com/Tracker?data=DVJrA7TbaSHoWZvxL--foowzGT77LPmehJOoPML5DOle2A_51c37s7Kzcz-Az7mGx8adJ7a9Rw4eGl7kGwyE-VQJuYIGzG8LodVu_rogI6Q=&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;Biotech Insider&lt;/a&gt; News Commentary — For most of medical history, the human body’s inability to regrow lost tissue has been treated as a limitation to be managed rather than a problem to be solved. When skin, bone, or soft tissue is destroyed by injury,</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/Regenerative+Medicine%E2%80%99s+Next+Chapter%3A+Inside+the+Race+to+Make+the+Body+Rebuild+Itself/26664866.html</guid>
   <pubDate>Thu, 18 Jun 2026 12:42:37 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">CNXU</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CNXU</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">IART</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">MDXG</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ORGO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">VCEL</category>
   	  </item>
  <item>
   <title>Regenerative Medicine’s Next Chapter: Inside the Race to Make the Body Rebuild Itself</title>
   <link>http://www.streetinsider.com/Globe+Newswire/Regenerative+Medicine%E2%80%99s+Next+Chapter%3A+Inside+the+Race+to+Make+the+Body+Rebuild+Itself/26664866.html</link>
   <description>&lt;p align=&quot;left&quot;&gt;&lt;em&gt;Issued on behalf of Conexeu Sciences Inc.&lt;/em&gt;&lt;/p&gt;  &lt;p align=&quot;left&quot;&gt;&lt;em&gt;A sector analysis of regenerative medicine — the science of restoring tissue rather than merely replacing it — and where a new generation of platform companies is trying to fit in.&lt;/em&gt;&lt;/p&gt;  &lt;p align=&quot;left&quot;&gt;NEW YORK, June  18, 2026  (GLOBE NEWSWIRE) -- &lt;a href=&quot;https://www.globenewswire.com/Tracker?data=DVJrA7TbaSHoWZvxL--foowzGT77LPmehJOoPML5DOle2A_51c37s7Kzcz-Az7mGx8adJ7a9Rw4eGl7kGwyE-VQJuYIGzG8LodVu_rogI6Q=&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;Biotech Insider&lt;/a&gt; News Commentary — For most of medical history, the human body’s inability to regrow lost tissue has been treated as a limitation to be managed rather than a problem to be solved. When skin, bone, or soft tissue is destroyed by injury,</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/Regenerative+Medicine%E2%80%99s+Next+Chapter%3A+Inside+the+Race+to+Make+the+Body+Rebuild+Itself/26664866.html</guid>
   <pubDate>Thu, 18 Jun 2026 12:42:37 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">CNXU</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CNXU</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">IART</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">MDXG</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ORGO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">VCEL</category>
   	  </item>
  <item>
   <title>Regenerative Medicine’s Next Chapter: Inside the Race to Make the Body Rebuild Itself</title>
   <link>http://www.streetinsider.com/Globe+Newswire/Regenerative+Medicine%E2%80%99s+Next+Chapter%3A+Inside+the+Race+to+Make+the+Body+Rebuild+Itself/26664866.html</link>
   <description>&lt;p align=&quot;left&quot;&gt;&lt;em&gt;Issued on behalf of Conexeu Sciences Inc.&lt;/em&gt;&lt;/p&gt;  &lt;p align=&quot;left&quot;&gt;&lt;em&gt;A sector analysis of regenerative medicine — the science of restoring tissue rather than merely replacing it — and where a new generation of platform companies is trying to fit in.&lt;/em&gt;&lt;/p&gt;  &lt;p align=&quot;left&quot;&gt;NEW YORK, June  18, 2026  (GLOBE NEWSWIRE) -- &lt;a href=&quot;https://www.globenewswire.com/Tracker?data=DVJrA7TbaSHoWZvxL--foowzGT77LPmehJOoPML5DOle2A_51c37s7Kzcz-Az7mGx8adJ7a9Rw4eGl7kGwyE-VQJuYIGzG8LodVu_rogI6Q=&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;Biotech Insider&lt;/a&gt; News Commentary — For most of medical history, the human body’s inability to regrow lost tissue has been treated as a limitation to be managed rather than a problem to be solved. When skin, bone, or soft tissue is destroyed by injury,</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/Regenerative+Medicine%E2%80%99s+Next+Chapter%3A+Inside+the+Race+to+Make+the+Body+Rebuild+Itself/26664866.html</guid>
   <pubDate>Thu, 18 Jun 2026 12:42:37 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">CNXU</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CNXU</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">IART</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">MDXG</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ORGO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">VCEL</category>
   	  </item>
  <item>
   <title>The Quiet Revolution in Regenerative Medicine: From Replacing Tissue to Rebuilding It</title>
   <link>http://www.streetinsider.com/Press+Releases/The+Quiet+Revolution+in+Regenerative+Medicine%3A+From+Replacing+Tissue+to+Rebuilding+It/26652262.html</link>
   <description>&lt;p align=&quot;left&quot;&gt;&lt;em&gt;Issued on behalf of Conexeu Sciences Inc.&lt;/em&gt;&lt;/p&gt;  &lt;p align=&quot;left&quot;&gt;&lt;em&gt;A new generation of tissue companies is betting that the future of wound care and reconstruction isn't a better patch — it's a material that helps the body regrow itself. One newly public name just took a concrete step toward proving it.&lt;/em&gt;&lt;/p&gt;  &lt;p align=&quot;left&quot;&gt;NEW YORK, June  16, 2026  (GLOBE NEWSWIRE) -- World Street Intelligence News Commentary — For most of medical history, the body's inability to regrow lost tissue has been treated as a fact to be managed rather than a problem to be solved. When skin,</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/The+Quiet+Revolution+in+Regenerative+Medicine%3A+From+Replacing+Tissue+to+Rebuilding+It/26652262.html</guid>
   <pubDate>Tue, 16 Jun 2026 10:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">CNXU</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">IART</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">MDXG</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ORGO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">VCEL</category>
   	  </item>
  <item>
   <title>The Quiet Revolution in Regenerative Medicine: From Replacing Tissue to Rebuilding It</title>
   <link>http://www.streetinsider.com/Press+Releases/The+Quiet+Revolution+in+Regenerative+Medicine%3A+From+Replacing+Tissue+to+Rebuilding+It/26652262.html</link>
   <description>&lt;p align=&quot;left&quot;&gt;&lt;em&gt;Issued on behalf of Conexeu Sciences Inc.&lt;/em&gt;&lt;/p&gt;  &lt;p align=&quot;left&quot;&gt;&lt;em&gt;A new generation of tissue companies is betting that the future of wound care and reconstruction isn't a better patch — it's a material that helps the body regrow itself. One newly public name just took a concrete step toward proving it.&lt;/em&gt;&lt;/p&gt;  &lt;p align=&quot;left&quot;&gt;NEW YORK, June  16, 2026  (GLOBE NEWSWIRE) -- World Street Intelligence News Commentary — For most of medical history, the body's inability to regrow lost tissue has been treated as a fact to be managed rather than a problem to be solved. When skin,</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/The+Quiet+Revolution+in+Regenerative+Medicine%3A+From+Replacing+Tissue+to+Rebuilding+It/26652262.html</guid>
   <pubDate>Tue, 16 Jun 2026 10:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">CNXU</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">IART</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">MDXG</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ORGO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">VCEL</category>
   	  </item>
  <item>
   <title>The Quiet Revolution in Regenerative Medicine: From Replacing Tissue to Rebuilding It</title>
   <link>http://www.streetinsider.com/Press+Releases/The+Quiet+Revolution+in+Regenerative+Medicine%3A+From+Replacing+Tissue+to+Rebuilding+It/26652262.html</link>
   <description>&lt;p align=&quot;left&quot;&gt;&lt;em&gt;Issued on behalf of Conexeu Sciences Inc.&lt;/em&gt;&lt;/p&gt;  &lt;p align=&quot;left&quot;&gt;&lt;em&gt;A new generation of tissue companies is betting that the future of wound care and reconstruction isn't a better patch — it's a material that helps the body regrow itself. One newly public name just took a concrete step toward proving it.&lt;/em&gt;&lt;/p&gt;  &lt;p align=&quot;left&quot;&gt;NEW YORK, June  16, 2026  (GLOBE NEWSWIRE) -- World Street Intelligence News Commentary — For most of medical history, the body's inability to regrow lost tissue has been treated as a fact to be managed rather than a problem to be solved. When skin,</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/The+Quiet+Revolution+in+Regenerative+Medicine%3A+From+Replacing+Tissue+to+Rebuilding+It/26652262.html</guid>
   <pubDate>Tue, 16 Jun 2026 10:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">CNXU</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">IART</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">MDXG</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ORGO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">VCEL</category>
   	  </item>
  <item>
   <title>The Quiet Revolution in Regenerative Medicine: From Replacing Tissue to Rebuilding It</title>
   <link>http://www.streetinsider.com/Press+Releases/The+Quiet+Revolution+in+Regenerative+Medicine%3A+From+Replacing+Tissue+to+Rebuilding+It/26652262.html</link>
   <description>&lt;p align=&quot;left&quot;&gt;&lt;em&gt;Issued on behalf of Conexeu Sciences Inc.&lt;/em&gt;&lt;/p&gt;  &lt;p align=&quot;left&quot;&gt;&lt;em&gt;A new generation of tissue companies is betting that the future of wound care and reconstruction isn't a better patch — it's a material that helps the body regrow itself. One newly public name just took a concrete step toward proving it.&lt;/em&gt;&lt;/p&gt;  &lt;p align=&quot;left&quot;&gt;NEW YORK, June  16, 2026  (GLOBE NEWSWIRE) -- World Street Intelligence News Commentary — For most of medical history, the body's inability to regrow lost tissue has been treated as a fact to be managed rather than a problem to be solved. When skin,</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/The+Quiet+Revolution+in+Regenerative+Medicine%3A+From+Replacing+Tissue+to+Rebuilding+It/26652262.html</guid>
   <pubDate>Tue, 16 Jun 2026 10:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">CNXU</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">IART</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">MDXG</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ORGO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">VCEL</category>
   	  </item>
  <item>
   <title>The Quiet Revolution in Regenerative Medicine: From Replacing Tissue to Rebuilding It</title>
   <link>http://www.streetinsider.com/Press+Releases/The+Quiet+Revolution+in+Regenerative+Medicine%3A+From+Replacing+Tissue+to+Rebuilding+It/26652262.html</link>
   <description>&lt;p align=&quot;left&quot;&gt;&lt;em&gt;Issued on behalf of Conexeu Sciences Inc.&lt;/em&gt;&lt;/p&gt;  &lt;p align=&quot;left&quot;&gt;&lt;em&gt;A new generation of tissue companies is betting that the future of wound care and reconstruction isn't a better patch — it's a material that helps the body regrow itself. One newly public name just took a concrete step toward proving it.&lt;/em&gt;&lt;/p&gt;  &lt;p align=&quot;left&quot;&gt;NEW YORK, June  16, 2026  (GLOBE NEWSWIRE) -- World Street Intelligence News Commentary — For most of medical history, the body's inability to regrow lost tissue has been treated as a fact to be managed rather than a problem to be solved. When skin,</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/The+Quiet+Revolution+in+Regenerative+Medicine%3A+From+Replacing+Tissue+to+Rebuilding+It/26652262.html</guid>
   <pubDate>Tue, 16 Jun 2026 10:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">CNXU</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">IART</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">MDXG</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ORGO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">VCEL</category>
   	  </item>
  <item>
   <title>The Quiet Revolution in Regenerative Medicine: From Replacing Tissue to Rebuilding It</title>
   <link>http://www.streetinsider.com/Globe+Newswire/The+Quiet+Revolution+in+Regenerative+Medicine%3A+From+Replacing+Tissue+to+Rebuilding+It/26652262.html</link>
   <description>&lt;p align=&quot;left&quot;&gt;&lt;em&gt;Issued on behalf of Conexeu Sciences Inc.&lt;/em&gt;&lt;/p&gt;  &lt;p align=&quot;left&quot;&gt;&lt;em&gt;A new generation of tissue companies is betting that the future of wound care and reconstruction isn't a better patch — it's a material that helps the body regrow itself. One newly public name just took a concrete step toward proving it.&lt;/em&gt;&lt;/p&gt;  &lt;p align=&quot;left&quot;&gt;NEW YORK, June  16, 2026  (GLOBE NEWSWIRE) -- World Street Intelligence News Commentary — For most of medical history, the body's inability to regrow lost tissue has been treated as a fact to be managed rather than a problem to be solved. When skin,</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/The+Quiet+Revolution+in+Regenerative+Medicine%3A+From+Replacing+Tissue+to+Rebuilding+It/26652262.html</guid>
   <pubDate>Tue, 16 Jun 2026 10:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">CNXU</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">IART</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">MDXG</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ORGO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">VCEL</category>
   	  </item>
  <item>
   <title>The Quiet Revolution in Regenerative Medicine: From Replacing Tissue to Rebuilding It</title>
   <link>http://www.streetinsider.com/Globe+Newswire/The+Quiet+Revolution+in+Regenerative+Medicine%3A+From+Replacing+Tissue+to+Rebuilding+It/26652262.html</link>
   <description>&lt;p align=&quot;left&quot;&gt;&lt;em&gt;Issued on behalf of Conexeu Sciences Inc.&lt;/em&gt;&lt;/p&gt;  &lt;p align=&quot;left&quot;&gt;&lt;em&gt;A new generation of tissue companies is betting that the future of wound care and reconstruction isn't a better patch — it's a material that helps the body regrow itself. One newly public name just took a concrete step toward proving it.&lt;/em&gt;&lt;/p&gt;  &lt;p align=&quot;left&quot;&gt;NEW YORK, June  16, 2026  (GLOBE NEWSWIRE) -- World Street Intelligence News Commentary — For most of medical history, the body's inability to regrow lost tissue has been treated as a fact to be managed rather than a problem to be solved. When skin,</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/The+Quiet+Revolution+in+Regenerative+Medicine%3A+From+Replacing+Tissue+to+Rebuilding+It/26652262.html</guid>
   <pubDate>Tue, 16 Jun 2026 10:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">CNXU</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">IART</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">MDXG</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ORGO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">VCEL</category>
   	  </item>
  <item>
   <title>The Quiet Revolution in Regenerative Medicine: From Replacing Tissue to Rebuilding It</title>
   <link>http://www.streetinsider.com/Globe+Newswire/The+Quiet+Revolution+in+Regenerative+Medicine%3A+From+Replacing+Tissue+to+Rebuilding+It/26652262.html</link>
   <description>&lt;p align=&quot;left&quot;&gt;&lt;em&gt;Issued on behalf of Conexeu Sciences Inc.&lt;/em&gt;&lt;/p&gt;  &lt;p align=&quot;left&quot;&gt;&lt;em&gt;A new generation of tissue companies is betting that the future of wound care and reconstruction isn't a better patch — it's a material that helps the body regrow itself. One newly public name just took a concrete step toward proving it.&lt;/em&gt;&lt;/p&gt;  &lt;p align=&quot;left&quot;&gt;NEW YORK, June  16, 2026  (GLOBE NEWSWIRE) -- World Street Intelligence News Commentary — For most of medical history, the body's inability to regrow lost tissue has been treated as a fact to be managed rather than a problem to be solved. When skin,</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/The+Quiet+Revolution+in+Regenerative+Medicine%3A+From+Replacing+Tissue+to+Rebuilding+It/26652262.html</guid>
   <pubDate>Tue, 16 Jun 2026 10:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">CNXU</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">IART</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">MDXG</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ORGO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">VCEL</category>
   	  </item>
  <item>
   <title>The Quiet Revolution in Regenerative Medicine: From Replacing Tissue to Rebuilding It</title>
   <link>http://www.streetinsider.com/Globe+Newswire/The+Quiet+Revolution+in+Regenerative+Medicine%3A+From+Replacing+Tissue+to+Rebuilding+It/26652262.html</link>
   <description>&lt;p align=&quot;left&quot;&gt;&lt;em&gt;Issued on behalf of Conexeu Sciences Inc.&lt;/em&gt;&lt;/p&gt;  &lt;p align=&quot;left&quot;&gt;&lt;em&gt;A new generation of tissue companies is betting that the future of wound care and reconstruction isn't a better patch — it's a material that helps the body regrow itself. One newly public name just took a concrete step toward proving it.&lt;/em&gt;&lt;/p&gt;  &lt;p align=&quot;left&quot;&gt;NEW YORK, June  16, 2026  (GLOBE NEWSWIRE) -- World Street Intelligence News Commentary — For most of medical history, the body's inability to regrow lost tissue has been treated as a fact to be managed rather than a problem to be solved. When skin,</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/The+Quiet+Revolution+in+Regenerative+Medicine%3A+From+Replacing+Tissue+to+Rebuilding+It/26652262.html</guid>
   <pubDate>Tue, 16 Jun 2026 10:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">CNXU</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">IART</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">MDXG</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ORGO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">VCEL</category>
   	  </item>
  <item>
   <title>The Quiet Revolution in Regenerative Medicine: From Replacing Tissue to Rebuilding It</title>
   <link>http://www.streetinsider.com/Globe+Newswire/The+Quiet+Revolution+in+Regenerative+Medicine%3A+From+Replacing+Tissue+to+Rebuilding+It/26652262.html</link>
   <description>&lt;p align=&quot;left&quot;&gt;&lt;em&gt;Issued on behalf of Conexeu Sciences Inc.&lt;/em&gt;&lt;/p&gt;  &lt;p align=&quot;left&quot;&gt;&lt;em&gt;A new generation of tissue companies is betting that the future of wound care and reconstruction isn't a better patch — it's a material that helps the body regrow itself. One newly public name just took a concrete step toward proving it.&lt;/em&gt;&lt;/p&gt;  &lt;p align=&quot;left&quot;&gt;NEW YORK, June  16, 2026  (GLOBE NEWSWIRE) -- World Street Intelligence News Commentary — For most of medical history, the body's inability to regrow lost tissue has been treated as a fact to be managed rather than a problem to be solved. When skin,</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/The+Quiet+Revolution+in+Regenerative+Medicine%3A+From+Replacing+Tissue+to+Rebuilding+It/26652262.html</guid>
   <pubDate>Tue, 16 Jun 2026 10:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">CNXU</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">IART</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">MDXG</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ORGO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">VCEL</category>
   	  </item>
 </channel>
</rss>
